BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson M. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231 [PMID: 32476788 DOI: 10.3748/wjg.v26.i18.2221]
URL: https://www.wjgnet.com/1007-9327/full/v26/i18/2221.htm
Number Citing Articles
1
Amera Elzubeir, Syed Munawer Alam. Letter to editor ‘prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with Rifaxamin’World Journal of Gastroenterology 2020; 26(44): 7085-7087 doi: 10.3748/wjg.v26.i44.7085
2
Xiao Y. Tong, Michael D. Norenberg, Michael J. Paidas, Nagarajarao Shamaladevi, Luis Salgueiro, Miklos Jaszberenyi, Binu John, Hussain Hussain, Omar El hiba, El got Abdeljalil, El-Mansoury Bilal, Sampath Natarajan, Rita Romaguera, Stanislav Papayan, Arianna K. Carden, Rajalakshmi Ramamoorthy, Nila Elumalai, Andrew V. Schally, Jayakumar Nithura, Rebecca Patrizio, Arumugam R. Jayakumar. Mechanism of Alzheimer type II astrocyte development in hepatic encephalopathyNeurochemistry International 2024; 180: 105866 doi: 10.1016/j.neuint.2024.105866
3
Juntao Tan, Yuxin He, Zhanbiao Li, Qinghua Zhang, Yanzhi Yang, Qian Xu, Xiaomei Xu. Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline FunctionsFrontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.919549
4
Bilal El-Mansoury, Omar El Hiba, Abdelaati El Khiat, El Baz Soraia, Arumugam Radhakrishnan Jayakumar. Physiology and Function of Glial Cells in Health and DiseaseAdvances in Bioinformatics and Biomedical Engineering 2023; : 223 doi: 10.4018/978-1-6684-9675-6.ch012
5
Robert S. Rahimi, Kimberly A. Brown, Steven L. Flamm, Robert S. Brown. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical OutcomesThe American Journal of Medicine 2021; 134(11): 1330 doi: 10.1016/j.amjmed.2021.06.007
6
Anam Fatima, Faridullah Shah, Hareema Saeed Khan, Kashif Rauf, Asif Jalil, Muhammad Saleem Akhter. Association Of Electroencephalogram Patterns With Ammonia Levels In Hepatic Encephalopathy PatientsJournal of Rawalpindi Medical College 2023; 27(3) doi: 10.37939/jrmc.v27i3.2041
7
Adam P. Buckholz, Robert S. Brown. Future Therapies of Hepatic EncephalopathyClinics in Liver Disease 2024; 28(2): 331 doi: 10.1016/j.cld.2024.02.002
8
Hong Yang, Jing Tian, Bingxia Meng, Ke Wang, Chu Zheng, Yanling Liu, Jingjing Yan, Qinghua Han, Yanbo Zhang. Application of Extreme Learning Machine in the Survival Analysis of Chronic Heart Failure Patients With High Percentage of Censored Survival TimeFrontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.726516
9
Mithun Sharma, Manasa Alla, Anand Kulkarni, Padaki Nagaraja Rao, Duvvur Nageshwar Reddy. Managing a Prospective Liver Transplant Recipient on the Waiting ListJournal of Clinical and Experimental Hepatology 2024; 14(1): 101203 doi: 10.1016/j.jceh.2023.06.003
10
Rehab Nady, Rasha R. Ahmed, Nadia Moustafa, Manal Abdul-Hamid. TNF-α blockage by etanercept restores spatial learning and reduces cellular degeneration in the hippocampus during liver cirrhosisTissue and Cell 2023; 85: 102249 doi: 10.1016/j.tice.2023.102249
11
Surbhi Trivedi, Katie Lam, Ashwin Ganesh, Yasir Hasnain, Wassim Hassan, Josi Herren, Ron C. Gaba. Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt CreationSeminars in Interventional Radiology 2023; 40(01): 009 doi: 10.1055/s-0043-1764282
12
Axel Holstege. Hepatische Enzephalopathie Teil 1: Definitionen, Pathogenese und DiagnostikGastroenterologie up2date 2023; 19(03): 241 doi: 10.1055/a-1984-7039
13
Steven L. Flamm. Key Insights and Clinical Pearls in the Identification and Management of Cirrhosis and Its ComplicationsThe American Journal of Medicine 2024; 137(10): 929 doi: 10.1016/j.amjmed.2024.05.015
14
Harry D Zacharias, Fady Kamel, Jaclyn Tan, Nina Kimer, Lise Lotte Gluud, Marsha Y Morgan. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosisCochrane Database of Systematic Reviews 2023; 2023(7) doi: 10.1002/14651858.CD011585.pub2
15
Tania Payo‐Serafín, Carolina Méndez‐Blanco, Paula Fernández‐Palanca, Jennifer Martínez‐Geijo, María Reviejo, Juan José Ortiz‐de‐Urbina, Javier González‐Gallego, Jose J. G. Marin, José L. Mauriz, Beatriz San‐Miguel. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled TrialsClinical Pharmacology & Therapeutics 2024; 116(2): 328 doi: 10.1002/cpt.3312
16
Chien-Hao Huang, Hsiao-Jung Tseng, Piero Amodio, Yu-Ling Chen, Sheng-Fu Wang, Shang-Hung Chang, Sen-Yung Hsieh, Chun-Yen Lin. Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis Improve Cirrhosis Outcome Prediction: A Modified Seven-Stage Model as a Clinical Alternative to MELDJournal of Personalized Medicine 2020; 10(4): 186 doi: 10.3390/jpm10040186
17
William S.A. Brusilow. Saul Brusilow: Understanding and treating diseases of ammonia toxicityAnalytical Biochemistry 2022; 636: 114478 doi: 10.1016/j.ab.2021.114478
18
Aalam Sohal, Victoria Green, Sunny Sandhu, Marina Roytman. Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy managementJournal of Community Hospital Internal Medicine Perspectives 2021; 11(5): 722 doi: 10.1080/20009666.2021.1954784
19
Yizhen Tian, Weihu Yang, Ruiying Yang, Qingqing Zhang, Luyang Hao, Enze Bian, Yuquan Yang, Xuewei Huang, Yongjie Wu, Baolai Zhang. Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5Toxicology and Applied Pharmacology 2022; 435: 115829 doi: 10.1016/j.taap.2021.115829
20
Yu Jun Wong, Jing Hong Loo. Albumin therapy for hepatic encephalopathy: current evidence and controversiesMetabolic Brain Disease 2023; 38(5): 1759 doi: 10.1007/s11011-022-01002-8
21
Richard J Aspinall, Mark Hudson, Stephen D Ryder, Paul Richardson, Elizabeth Farrington, Mark Wright, Robert T Przemioslo, Francisco Perez, Melanie Kent, Roland Henrar, Joe Hickey, Debbie L Shawcross. Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)Frontline Gastroenterology 2023; 14(3): 228 doi: 10.1136/flgastro-2022-102221
22
Yevedzo Ntuli, Debbie L. Shawcross. Infection, inflammation and hepatic encephalopathy from a clinical perspectiveMetabolic Brain Disease 2024;  doi: 10.1007/s11011-024-01402-y
23
Yeniffer Bermúdez, Sandra Neri, Cesar Morao, Ana López, Dayana Lombano, Genesis Rojas, Milagros Miquilena, Yauribel Martínez, Ayerim Higuera. Impacto de la desnutrición y sarcopenia en pacientes pediátricos con cirrosis hepáticaRevista GEN 2024; 78(1): 11 doi: 10.61155/2024.78.1.003
24
Hoor Al Kaabi, Abdullah M. Al Alawi, Zubaida Al Falahi, Zakariya Al-Naamani, Said A. Al Busafi. Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver CirrhosisJournal of Clinical Medicine 2023; 12(17): 5756 doi: 10.3390/jcm12175756
25
Lívia Guimarães, Juliana Piedade, Joana Duarte, Caroline Baldin, Lívia Victor, Barbara Costa, Zulane Veiga, Camila Alcântara, Flávia Fernandes, Gustavo Pereira. Hepatic Encephalopathy in Cirrhotic Patients With Bacterial Infections: Frequency, Clinical Characteristics, and Prognostic RelevanceJournal of Clinical and Experimental Hepatology 2023; 13(4): 559 doi: 10.1016/j.jceh.2023.01.004